C. Lowry Barnes
Sourced from institutional research profiles (UAMS TRI or ARA).
Researcher
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
C. Lowry Barnes' research focuses on orthopedic surgery, particularly total joint arthroplasty for hip and knee replacements. This work includes investigating factors that influence surgical decisions, such as patient obesity, and assessing outcomes in diverse patient populations. Barnes has also examined the impact of external events, like the COVID-19 pandemic, on the delivery of orthopedic care and hospitalization outcomes for Medicare beneficiaries.
Further research by Barnes delves into the biological mechanisms underlying bone health and resorption. This includes studies on osteocyte function, the role of specific proteins like osteoprotegerin, and the impact of genetic factors, such as Piezo1 expression, on age-associated bone loss. Barnes also explores patient perceptions of surgical technologies, including robotic-assisted orthopedic surgery, through methods like online crowdsourcing.
Barnes holds a significant publication record with over 426 publications and a citation count exceeding 4,600, reflecting a highly cited researcher status. Key collaborators include Jeffrey B. Stambough, Simon C. Mears, Benjamin M. Stronach, and Elena Ambrogini, all from the University of Arkansas for Medical Sciences, with whom Barnes has co-authored numerous publications.
Metrics
- h-index: 38
- Publications: 426
- Citations: 4,639
Selected Publications
-
Nutritional Marker Screening in Total Joint Arthroplasty: Current Practice Patterns and Associations With Outcomes (2026)
-
Promising Clinical Outcomes Using Rotational Achilles Autograft for Knee Arthroplasty Terrible Triad (2026)
-
Periarticular Injection for Pain Control after Surgical Treatment of Knee Periprosthetic Joint Infection (2026)
-
Impact of osteoporosis on post-operative outcomes following rotator cuff repair (2026)
-
Implant Costs Consume a Large Proportion of the Reimbursement in Revision Hip and Knee Arthroplasty (2026)
-
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
-
Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
-
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
-
Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
-
Validation of a novel genomic biomarker of mesenchymal stem cell scalability and implications of genotype status on cellular senescence phenotypes (2026)
-
Postoperative complications following total shoulder arthroplasty in multiple myeloma patients with prior bone marrow transplantation (2026)
-
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
-
Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition (2025)
-
Examining the Effects of Quercetin on Phenotypic Characteristics of Human Mesenchymal Stem Cells (2025)
-
Phenotypic changes associated with continuous long term in vitro expansion of bone marrow-derived mesenchymal stem cells (2025)
Grants & Funding
As listed on this researcher's institutional profile.
- An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects with Thrombocytopenia Scheduled for a Surgical Procedure Dova Pharmaceuticals, Inc.
- Comparative Effectiveness of Pulmonary Embolism Prevention after Hip and Knee Replacement (PEPPER): Balancing Safety and Effectiveness - Continuation - Continuation Patient-Centered Outcomes Research Institute via Medical University of South Carolina
- Integrated Versus Referral Care for Complex Psychiatric Disorders in Rural FQHCs - Continuation - Continuation - Continuation - Continuation Patient-Centered Outcomes Research Institute via University of Washington
Collaboration Network
Top Collaborators
- Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation
- Piezo1 opposes age‐associated cortical bone loss
- Social Needs of Patients Undergoing Total Joint Arthroplasty
- The Medial Pivot Design in Total Knee Arthroplasty
- The Influence of Knee Osteoarthritis on Spinopelvic Alignment and Global Sagittal Balance
Showing 5 of 29 shared publications
- Piezo1 opposes age‐associated cortical bone loss
- Social Needs of Patients Undergoing Total Joint Arthroplasty
- The Medial Pivot Design in Total Knee Arthroplasty
- The Influence of Knee Osteoarthritis on Spinopelvic Alignment and Global Sagittal Balance
- Extensor Mechanism Disruption Remains a Challenging Problem
Showing 5 of 28 shared publications
- The Initial Impact of COVID-19 on Total Hip and Knee Arthroplasty
- Piezo1 opposes age‐associated cortical bone loss
- The Medial Pivot Design in Total Knee Arthroplasty
- Extensor Mechanism Disruption Remains a Challenging Problem
- Sepsis and Total Joint Arthroplasty
Showing 5 of 19 shared publications
- The Influence of Knee Osteoarthritis on Spinopelvic Alignment and Global Sagittal Balance
- Changes in Mediolateral Postural Control Mechanisms During Gait After Total Knee Arthroplasty
- Kinematic Performance of Medial Pivot Total Knee Arthroplasty
- Management of Periprosthetic Joint Infection and Extensor Mechanism Disruption With Modular Knee Fusion: Clinical and Biomechanical Outcomes
- Inter-Rater Reliability of Clinical Testing for Laxity After Knee Arthroplasty
Showing 5 of 8 shared publications
- Single-Cell Transcriptomic Analysis Identifies Senescent Osteocytes That Trigger Bone Destruction in Breast Cancer Metastasis
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
Showing 5 of 8 shared publications
- Single-Cell Transcriptomic Analysis Identifies Senescent Osteocytes That Trigger Bone Destruction in Breast Cancer Metastasis
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
Showing 5 of 8 shared publications
- Single-Cell Transcriptomic Analysis Identifies Senescent Osteocytes That Trigger Bone Destruction in Breast Cancer Metastasis
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
Showing 5 of 7 shared publications
- Social Needs of Patients Undergoing Total Joint Arthroplasty
- Does In-Hospital Opioid Use Affect Opioid Consumption After Total Joint Arthroplasty?
- Successful Transition to Same Calendar Day Discharge in Total Joint Arthroplasty at an Academic Center
- Articulating Hip Spacers with a Constrained Acetabular Liner: Effect of Acetabular Bone Loss and Cementation Quality
- Periarticular Injection for Pain Control after Surgical Treatment of Knee Periprosthetic Joint Infection
- Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation
- Piezo1 opposes age‐associated cortical bone loss
- Single-Cell Transcriptomic Analysis Identifies Senescent Osteocytes That Trigger Bone Destruction in Breast Cancer Metastasis
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- The Initial Impact of COVID-19 on Total Hip and Knee Arthroplasty
- Racial and Ethnic Disparities in Hospitalization Outcomes Among Medicare Beneficiaries During the COVID-19 Pandemic
- The National Trend in Arthroplasty Surgery Location and the Economic Impact on Surgeons, Hospitals and ASCs
- Worsening Arthroplasty Utilization With Widening Racial Variance During the COVID-19 Pandemic
Similar Researchers
Based on overlapping research topics